2cureX announced that Kenneth Graabek Johansen has been appointed new CFO and will start on 1 February 2021. Kenneth has a strong track record in business administration at executive level in the biomedical area. With positions such as COO and Co-founder of JADBio, Kenneth will add many years of experience in strengthening the business and financial development dimension, which is key to positioning 2cureX as a world leader in Functional Precision Medicine.